Dr Sven Gallasch
Sven Gallasch is a Lecturer in Law and a Faculty Member of the Centre for Competition Policy. Prior to his current position at UEA Law School Sven has worked as a Research Associate at the Centre for Competition Policy.
Originally educated at the University of Trier and the University of Augsburg in Germany, Sven holds a German Diploma in Law. He has also been awarded with a LLM in Competition Law and Policy from UEA. After having been awarded a full UEA scholarship, Sven started his doctoral studies at UEA Law School and the ESRC Centre for Competition Policy. His doctoral thesis is entitled ‘The anticompetitive misuse of intellectual property rights in the European pharmaceutical sector’. It was examined by Prof. Ariel Ezrachi and Prof. Bill Kovacic and has been passed with no corrections. During his doctoral studies he already taught EU Law and Competition Law as an Associate Tutor at UEA Law School and Competition Law as a Guest Tutor at the University of Leicester.
Sven has recently been invited to address the 7th UN Conference to Review the UN Set on Competition Policy as key note speaker for the for round table on "the role of competition in the pharmaceutical sector and its benefits for consumers". He has also taught a course on European Antitrust as a Visiting Professor at the University of Stetson College of Law in Gulfport, Florida.
Research Associate at the Centre for Competition Policy
Associate Tutor at UEA Law School
Guest Tutor at the University of Leicester
Visiting Professor at the University of Stetson College of Law
Activating Actavis in Europe – the proposal of a ‘structured effects-based’ analysis for pay-for-delay settlements,
in Legal Studies
pp. 683–705Full Text UEA Repository
Debunking the pay for delay myth: pay for delay settlements are no ordinary patent settlements,
in Competition Law Journal
pp. 89-95UEA Repository
A new dimension to EU pharma antitrust product hopping and unilateral pay for delay,
in European Competition Journal
pp. 137-158Full Text UEA Repository
The referral of Huawei v ZTE to the CJEU:Determining the future of remedies in the context of standard-essential patents,
in European Competition Law Review
pp. 443-445UEA Repository
AstraZeneca v the Walker Process—a real EU–US divergence or just an attempt to compare apples to oranges?,
in European Competition Journal
pp. 505-526Full Text UEA Repository
Key Research Interests
Sven’s main research interest is the intersection of competition law and intellectual property rights. His doctoral thesis addresses the anticompetitive misuse of intellectual property rights in the pharmaceutical sector and especially focuses on so-called reverse payment settlements, employing comparative legal analysis and law & economics. During his doctoral studies, he was accepted as a visiting scholar at the Tilburg Law & Economics Centre (TILEC) at Tilburg University in the Netherlands. His research has been published in well-respected peer-reviewd journal including Legal Studies and European Competition Journal.
Sven has further broadened his research interest to more general enforcement issues in relation to intellectual property rights and their impact on competition. This is marked by his most recent case note published in the European Competition Law Review (ECLR) concerning the use of remedies in the context of standard-essential patents.
Most recently, he has initiated the joint research project Increasing access to affordable medicine in developing countries and least developed countries: between regulation and competition. The project is official approved and supported by the United Nation Conference for Trade and Development and is run under its Reseach Partnership Platform.